{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:30:12Z","timestamp":1792791012702,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Photonics Innovation Center at University of Toronto","id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ontario Research Fund"},{"name":"Theralase Technologies Inc."},{"DOI":"10.13039\/100004316","name":"International Business Machines Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002418","name":"Intel Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Harvard Presidential Scholarship"},{"name":"Howard Cox MD\/PhD Fellowship, Harvard Medical School"},{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Spinal metastases often occur in the advanced stages of breast, lung or prostate cancer, resulting in a significant impact on the patient\u2019s quality of life. Current treatment modalities for spinal metastases include both systemic and localized treatments that aim to decrease pain, improve mobility and structural stability, and control tumour growth. With the development of non-toxic photosensitizer drugs, photodynamic therapy\u00a0(PDT) has shown promise as a minimally invasive non-thermal alternative in oncology, including for spinal metastases. To apply PDT to spinal metastases, predictive algorithms that optimize tumour treatment and minimize the risk of spinal cord damage are needed to assess the feasibility of the treatment and encourage a broad acceptance of PDT in clinical trials. This work presents a framework for PDT modelling and planning, and simulates the feasibility of using a BPD-MA mediated PDT to treat bone metastases at two different wavelengths\u00a0(690\u00a0nm and 565\u00a0nm). An open-source software for PDT planning, PDT-SPACE, is used to evaluate different configurations of light diffusers (cut-end and cylindrical) fibres with optimized power allocation in order to minimize the damage to spinal cord or maximize tumour destruction. The work is simulated on three CT images of metastatically involved vertebrae acquired from three patients with spinal metastases secondary to colorectal or lung cancer. Simulation results show that PDT at a\u00a0565\u00a0nm wavelength has the ability to treat\u00a090% of the metastatic lesion with less than\u00a017% damage to the spinal cord. However, the energy required, and hence treatment time, to achieve this outcome with the\u00a0565\u00a0nm is infeasible. The energy required and treatment time for the longer wavelength of\u00a0690\u00a0nm is feasible\u00a0(\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$${\\sim }\\,40$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mrow>\n                            <mml:mo>\u223c<\/mml:mo>\n                            <mml:mspace\/>\n                            <mml:mn>40<\/mml:mn>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    \u00a0min), but treatment aimed at\u00a090% of the metastatic lesion would severely damage the proximal spinal cord. PDT-SPACE provides a simulation platform that can be used to optimize PDT delivery in the metastatic spine. While this work serves as a prospective methodology to analyze the feasibility of PDT for tumour ablation in the spine, preclinical studies in an animal model are ongoing to elucidate the spinal cord damage extent as a function of PDT dose, and the resulting short and long term functional impairments. These will be required before there can be any consideration of clinical trials.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-97407-z","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T06:06:24Z","timestamp":1631167584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Photodynamic therapy outcome modelling for patients with spinal metastases: a simulation-based study"],"prefix":"10.1038","volume":"11","author":[{"given":"Abdul-Amir","family":"Yassine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C. Y.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Saeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallis","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari M.","family":"Whyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete K.","family":"Akens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaughn","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Lilge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"97407_CR1","first-page":"20","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo, F. et al. Bone metastases: An overview. Oncol. Rev. 11, 20 (2017).","journal-title":"Oncol. Rev."},{"key":"97407_CR2","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2016.6.FOCUS16166","volume":"41","author":"D Bakar","year":"2016","unstructured":"Bakar, D. et al. Decompression surgery for spinal metastases: A systematic review. Neurosug. Focus 41, E2 (2016).","journal-title":"Neurosug. Focus"},{"key":"97407_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3171\/2017.1.SPINE16684","volume":"27","author":"ZA Husain","year":"2017","unstructured":"Husain, Z. A. et al. Stereotactic body radiotherapy for de novo spinal metastases: Systematic review: International stereotactic radiosurgery society practice guidelines. J. Neurosurg. Spine 27, 295\u2013302 (2017).","journal-title":"J. Neurosurg. Spine"},{"key":"97407_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/os.12334","volume":"9","author":"M Curtin","year":"2017","unstructured":"Curtin, M. et al. Spinal metastatic disease: A review of the role of the multidisciplinary team. Orthop. Surg. 9, 145\u2013151 (2017).","journal-title":"Orthop. Surg."},{"key":"97407_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11864-017-0516-7","volume":"18","author":"NM Kam","year":"2017","unstructured":"Kam, N. M. et al. Combined vertebral augmentation and radiofrequency ablation in the management of spinal metastases: An update. Curr. Treat. Opt. Oncol. 18, 74 (2017).","journal-title":"Curr. Treat. Opt. Oncol."},{"key":"97407_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/ncponc1323","volume":"6","author":"L Costa","year":"2009","unstructured":"Costa, L. & Major, P. P. Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nat. Rev. Clin. Oncol. 6, 163\u2013174 (2009).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"97407_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","volume":"126","author":"SE Rich","year":"2018","unstructured":"Rich, S. E. et al. Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radio. Oncol. 126, 547\u2013557 (2018).","journal-title":"Radio. Oncol."},{"key":"97407_CR8","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","volume":"16","author":"I Thibault","year":"2015","unstructured":"Thibault, I. et al. Response assessment after stereotactic body radiotherapy for spinal metastasis: A report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol. 16, e595\u2013e603 (2015).","journal-title":"Lancet Oncol."},{"key":"97407_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF01053419","volume":"23","author":"CM Faul","year":"1995","unstructured":"Faul, C. M. & Flickinger, J. C. The use of radiation in the management of spinal metastases. J. Neuro-oncol. 23, 149\u2013161 (1995).","journal-title":"J. Neuro-oncol."},{"key":"97407_CR10","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1016\/S1470-2045(13)70101-3","volume":"14","author":"A Sahgal","year":"2013","unstructured":"Sahgal, A., Whyne, C. M., Ma, L., Larson, D. A. & Fehlings, M. G. Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases. Lancet Oncol. 14, e310\u2013e320 (2013).","journal-title":"Lancet Oncol."},{"key":"97407_CR11","doi-asserted-by":"publisher","first-page":"25691","DOI":"10.18632\/oncotarget.14823","volume":"8","author":"F De Felice","year":"2017","unstructured":"De Felice, F., Piccioli, A., Musio, D. & Tombolini, V. The role of radiation therapy in bone metastases management. Oncotarget 8, 25691 (2017).","journal-title":"Oncotarget"},{"key":"97407_CR12","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","volume":"27","author":"PS Rose","year":"2009","unstructured":"Rose, P. S. et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J. Clin. Oncol. 27, 5075 (2009).","journal-title":"J. Clin. Oncol."},{"key":"97407_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.rpor.2015.03.004","volume":"20","author":"C Greco","year":"2015","unstructured":"Greco, C. et al. Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT. Rep. Pract. Oncol. Radiol. 20, 454\u2013463 (2015).","journal-title":"Rep. Pract. Oncol. Radiol."},{"key":"97407_CR14","first-page":"20","volume":"20","author":"T Mayer","year":"2020","unstructured":"Mayer, T. et al. Spinal metastases treated with bipolar radiofrequency ablation with increased ($$> 70^{\\circ }$$ C) target temperature: Pain management and local tumor control. Diag. Interv. Imag. 20, 20 (2020).","journal-title":"Diag. Interv. Imag."},{"key":"97407_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/jor.22373","volume":"31","author":"VC Lo","year":"2013","unstructured":"Lo, V. C. et al. The benefits of photodynamic therapy on vertebral bone are maintained and enhanced by combination treatment with bisphosphonates and radiation therapy. J. Orthop. Res. 31, 1398\u20131405 (2013).","journal-title":"J. Orthop. Res."},{"key":"97407_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10549-012-2146-x","volume":"135","author":"VC Lo","year":"2012","unstructured":"Lo, V. C. et al. Beyond radiation therapy: Photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model. Breast Cancer Res. Treat. 135, 391\u2013401 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"97407_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10549-011-1854-y","volume":"133","author":"L Wise-Milestone","year":"2012","unstructured":"Wise-Milestone, L. et al. Local treatment of mixed osteolytic\/osteoblastic spinal metastases: Is photodynamic therapy effective?. Breast Cancer Res. Treat. 133, 899\u2013908 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"97407_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.orthres.2004.12.014","volume":"23","author":"S Burch","year":"2005","unstructured":"Burch, S. et al. Photodynamic therapy for the treatment of vertebral metastases in a rat model of human breast carcinoma. J. Orthop. Res. 23, 995\u20131003 (2005).","journal-title":"J. Orthop. Res."},{"key":"97407_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-009-0356-7","volume":"119","author":"MK Akens","year":"2010","unstructured":"Akens, M. K. et al. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer bpd-ma (verteporfin). Breast Cancer Res. Treat. 119, 325 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"97407_CR20","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1158\/1078-0432.CCR-19-0673","volume":"25","author":"C Fisher","year":"2019","unstructured":"Fisher, C. et al. Photodynamic therapy for the treatment of vertebral metastases: A phase I clinical trial. Clin. Cancer Res. 25, 5766\u20135776 (2019).","journal-title":"Clin. Cancer Res."},{"key":"97407_CR21","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1088\/0031-9155\/53\/9\/R01","volume":"53","author":"BC Wilson","year":"2008","unstructured":"Wilson, B. C. & Patterson, M. S. The physics, biophysics and technology of photodynamic therapy. Phys. Med. Biol. 53, R61 (2008).","journal-title":"Phys. Med. Biol."},{"key":"97407_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1751-1097.1994.tb05042.x","volume":"59","author":"B Aveline","year":"1994","unstructured":"Aveline, B., Hasan, T. & Redmond, R. W. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem. Photobiol. 59, 328\u2013335 (1994).","journal-title":"Photochem. Photobiol."},{"key":"97407_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1364\/BOE.9.000898","volume":"9","author":"A-A Yassine","year":"2018","unstructured":"Yassine, A.-A. et al. Automatic interstitial photodynamic therapy planning via convex optimization. Biomed. Opt. Express 9, 898\u2013920 (2018).","journal-title":"Biomed. Opt. Express"},{"key":"97407_CR24","doi-asserted-by":"publisher","first-page":"e201800153","DOI":"10.1002\/jbio.201800153","volume":"12","author":"A-A Yassine","year":"2019","unstructured":"Yassine, A.-A., Lilge, L. & Betz, V. Optimizing interstitial photodynamic therapy with custom cylindrical diffusers. J. Biophoton. 12, e201800153 (2019).","journal-title":"J. Biophoton."},{"key":"97407_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1751-1097.1998.tb09698.x","volume":"68","author":"TJ Farrell","year":"1998","unstructured":"Farrell, T. J., Wilson, B. C., Patterson, M. S. & Olivo, M. C. Comparison of the in vivo photodynamic threshold dose for photofrin, mono-and tetrasulfonated aluminum phthalocyanine using a rat liver model. Photochem. Photobiol. 68, 394\u2013399 (1998).","journal-title":"Photochem. Photobiol."},{"key":"97407_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.37358\/MP.17.1.4775","volume":"54","author":"S Simionescu","year":"2017","unstructured":"Simionescu, S., Teodorescu, S., Ion, R. M., Voicila, E. & Nechifor, G. Polymeric membrane for verteporfirin purification. Mater. Plast. 54, 14 (2017).","journal-title":"Mater. Plast."},{"key":"97407_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich, P. A. et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage 31, 1116\u20131128 (2006).","journal-title":"Neuroimage"},{"key":"97407_CR28","doi-asserted-by":"publisher","first-page":"085001","DOI":"10.1117\/1.JBO.23.8.085001","volume":"23","author":"J Cassidy","year":"2018","unstructured":"Cassidy, J., Nouri, A., Betz, V. & Lilge, L. High-performance, robustly verified Monte Carlo simulation with FullMonte. J. Biomed. Opt. 23, 085001 (2018).","journal-title":"J. Biomed. Opt."},{"key":"97407_CR29","first-page":"20","volume":"717","author":"J Ahrens","year":"2005","unstructured":"Ahrens, J., Geveci, B. & Law, C. P. An end-user tool for large data visualization. Visual. Handb. 717, 20 (2005).","journal-title":"Visual. Handb."},{"key":"97407_CR30","doi-asserted-by":"publisher","first-page":"034011","DOI":"10.1117\/1.1921887","volume":"10","author":"S Burch","year":"2005","unstructured":"Burch, S. et al. Photodynamic therapy for the treatment of metastatic lesions in bone: Studies in rat and porcine models. J. Biomed. Opt. 10, 034011 (2005).","journal-title":"J. Biomed. Opt."},{"key":"97407_CR31","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1088\/0031-9155\/58\/11\/R37","volume":"58","author":"SL Jacques","year":"2013","unstructured":"Jacques, S. L. Optical properties of biological tissues: A review. Phys. Med. Biol. 58, R37-61 (2013).","journal-title":"Phys. Med. Biol."},{"key":"97407_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/jbio.201100062","volume":"4","author":"JL Sandell","year":"2011","unstructured":"Sandell, J. L. & Zhu, T. C. A review of in-vivo optical properties of human tissues and its impact on PDT. J. Biophoton. 4, 773\u2013787 (2011).","journal-title":"J. Biophoton."},{"key":"97407_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/tnsci-2018-0012","volume":"9","author":"A Shuaib","year":"2018","unstructured":"Shuaib, A. & Bourisly, A. K. Photobiomodulation optimization for spinal cord injury rat phantom model. Trans. Neurosci. 9, 67\u201371 (2018).","journal-title":"Trans. Neurosci."},{"key":"97407_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1142\/S1793545811001319","volume":"04","author":"AN Bashkatov","year":"2011","unstructured":"Bashkatov, A. N., Genina, E. A. & Tuchin, V. V. Optical properties of skin, subcutaneous, and muscle tissues: A review. J. Innov. Opt. Health Sci. 04, 9\u201338 (2011).","journal-title":"J. Innov. Opt. Health Sci."},{"key":"97407_CR35","doi-asserted-by":"publisher","first-page":"075006","DOI":"10.1117\/1.JBO.23.7.075006","volume":"23","author":"N Honda","year":"2018","unstructured":"Honda, N., Ishii, K., Kajimoto, Y., Kuroiwa, T. & Awazu, K. Determination of optical properties of human brain tumor tissues from 350 to 1000 nm to investigate the cause of false negatives in fluorescence-guided resection with 5-aminolevulinic acid. J. Biomed. Opt. 23, 075006 (2018).","journal-title":"J. Biomed. Opt."},{"key":"97407_CR36","doi-asserted-by":"publisher","first-page":"015006","DOI":"10.1117\/1.JBO.22.1.015006","volume":"22","author":"SKV Sekar","year":"2017","unstructured":"Sekar, S. K. V. et al. Diffuse optical characterization of collagen absorption from 500 to 1700 nm. J. Biomed. Opt. 22, 015006 (2017).","journal-title":"J. Biomed. Opt."},{"key":"97407_CR37","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/j.1751-1097.2007.00172.x","volume":"83","author":"MK Akens","year":"2007","unstructured":"Akens, M. K. et al. Photodynamic therapy of vertebral metastases: Evaluating tumor-to-neural tissue uptake of BPD-MA and ALA-PpIX in a murine model of metastatic human breast carcinoma. Photochem. Photobiol. 83, 1034\u20131039 (2007).","journal-title":"Photochem. Photobiol."},{"key":"97407_CR38","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/bjc.1996.58","volume":"73","author":"L Lilge","year":"1996","unstructured":"Lilge, L. et al. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. Br. J. Cancer 73, 332\u2013343 (1996).","journal-title":"Br. J. Cancer"},{"key":"97407_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/1011-1344(95)07222-5","volume":"33","author":"R Gillies","year":"1996","unstructured":"Gillies, R., Kollias, N., Hasan, T. & Diddens, H. Spectral characterization of the benzoporphyrin derivative monoacid ring\u2014a photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation. J. Photochem. Photobiol. B Biol. 33, 87\u201390 (1996).","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"97407_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-09932-5","volume":"7","author":"Y-CC Chang","year":"2017","unstructured":"Chang, Y.-C.C. et al. Delineation of tumor habitats based on dynamic contrast enhanced MRI. Sci. Rep. 7, 1\u201314 (2017).","journal-title":"Sci. Rep."},{"key":"97407_CR41","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1039\/C6CS00271D","volume":"45","author":"Z Zhou","year":"2016","unstructured":"Zhou, Z., Song, J., Nie, L. & Chen, X. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem. Soc. Rev. 45, 6597\u20136626 (2016).","journal-title":"Chem. Soc. Rev."},{"key":"97407_CR42","unstructured":"Ferguson, D. The Impact of Photodynamic and Radiation Therapies in the Metastatic Spine. Master\u2019s thesis (2020)."},{"key":"97407_CR43","doi-asserted-by":"publisher","first-page":"028002","DOI":"10.1117\/1.JBO.21.2.028002","volume":"21","author":"J Swartling","year":"2016","unstructured":"Swartling, J. et al. Online dosimetry for temoporfin-mediated interstitial photodynamic therapy using the canine prostate as model. J. Biomed. Opt. 21, 028002 (2016).","journal-title":"J. Biomed. Opt."},{"key":"97407_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/php.13066","volume":"95","author":"I Rizvi","year":"2019","unstructured":"Rizvi, I. et al. A combination of visudyne and a lipid-anchored liposomal formulation of benzoporphyrin derivative enhances photodynamic therapy efficacy in a 3D model for ovarian cancer. Photochem. Photobiol. 95, 419\u2013429 (2019).","journal-title":"Photochem. Photobiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97407-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97407-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97407-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T22:11:43Z","timestamp":1675635103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97407-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97407"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97407-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Lilge is appointed on the Medical and Scientific Advisory Board of Theralase Technologies Inc. Theralase Technologies Inc. has no interest in commercializing the software tool, nor this particular indication. Hence, no conflict of interest is present. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17871"}}